Eli Lilly and Company

NYSE:LLY

Sector

🏥 Health Care

Industries

🔬 Clinical Trials

💊 Drugstores & Retail Pharmacies

💊 Pharmaceuticals

Location

United States

Market Cap

USD 729.58 B

Share Price

USD 808.11

Avg Daily Volume

4,009,380

Change (1 day)

-0.56%

Change (1 year)

0.43%

Change (YTD)

4.68%

Eli Lilly and Company Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2025: 76.92%

Eli Lilly and Company Return on Equity (ROE) is 76.92% for the Trailing 12 Months (TTM) ending March 31, 2025, a 43.69% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.

Eli Lilly and Company Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2024 was 53.53%, a -4.80% change year over year.
Eli Lilly and Company Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2023 was 56.23%, a -25.44% change year over year.
Eli Lilly and Company Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2022 was 75.41%, a -33.59% change year over year.
Eli Lilly and Company Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2021 was 113.56%, a -39.21% change year over year.